615-20-3Clc1nc2ccccc2s1BSQLQMLFTHJVKS-UHFFFAOYSA-N615-20-3DTXSID2052289CHEMBL4559874Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H301 (83.3%): Toxic if swallowed [Danger Acute toxicity, oral]
P260, P264, P264+P265, P270, P271, P273, P280, P284, P301+P316, P301+P317, P304+P340, P305+P351+P338, P316, P320, P321, P330, P337+P317, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 48 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Benzothiazole, 2-chloro-
Status: Cease Manufacture Update: 25-10-2012 https://echa.europa.eu/registration-dossier/-/registered-dossier/10968
Benzothiazole, 2-chloro-: Does not have an individual approval but may be used under an appropriate group standard
Uses2-Chloro-1,3-benzothiazole is used in the synthesis of CBTs which are good building blocks for bioluminescent compounds for imaging.
Uses2-Chlorobenzothiazole was used in the synthesis of:(RS)- and (S)-lubeluzole(1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives4H-thieno[2′,3′:4,5]pyrimido[2,1-b]benzothiazole derivatives
Loading…